Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 721Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1LGM Pharma

02 1Jai Radhe Sales

03 1Acura Labs

04 1Alembic Pharmaceuticals Limited

05 1Anwita Drugs & Chemicals Pvt Ltd

06 1Asia Pioneer Pharmaceuticals

07 1CHEMO

08 1Chromo Laboratories

09 1HELM Portugal

10 1Hetero Drugs

11 1Jiangsu Zhongbang Pharmaceutical Co, Ltd

12 1Smilax Laboratories Limited

13 1Suzhou Tianlu Bio-pharmaceutical Co., Ltd

14 1TAPI Technology & API Services

15 1Teva Pharmaceutical Industries

16 1Titan Laboratories

17 1Viatris

18 1Zhejiang Huahai Pharmaceutical

19 1Zhejiang Tianyu Pharmaceutical Co., Ltd

20 1Zhuhai Rundu Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

LGM Pharma

U.S.A
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Candesartan Cilexetil

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Candesartan Cilexetil

About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...

Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete sourcing solutions for pharmaceutical products from India, including technical and regulatory assistance. It believes in providing its customers with high-quality products at reasonable prices. It has always endeavored to achieve global standards in the field of pharmaceuticals and has carved out a niche for itself through new methods based on current market needs. Today, it has established itself as a truly global company, with exports to almost every continent.
Jai Radhe Sales

03

Acura Labs

India
Fi Europe 2024
Not Confirmed
arrow

Acura Labs

India
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Acura Labs is one of the fastest-growing pharmaceutical companies backed by a solid and innovative R&D facility and a top-notch Active Pharmaceutical Ingredients (APIs) manufacturi...

Acura Labs is one of the fastest-growing pharmaceutical companies backed by a solid and innovative R&D facility and a top-notch Active Pharmaceutical Ingredients (APIs) manufacturing facility. We have a robust product portfolio of APIs spread across various therapeutic areas, capable of handling novel, complex and critical reactions. We are equipped with adaptable, versatile, and cutting-edge infrastructure tailored to fit any complex chemistry molecules and satisfy the needs of global innovators.
blank

04

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutica...

Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates.
blank

05

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : ANWITA offers a range of “turn-key” product development, project management and consultancy services. And has expertise to manage your product development projects from formula...

ANWITA offers a range of “turn-key” product development, project management and consultancy services. And has expertise to manage your product development projects from formulation design up to international products registration. We specialize in the design, development, implementation and improvement of your solid, semi-solid and liquid applications, technologies and manufacturing technologies.
blank

06

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Asia Pioneer Pharmaceuticals is a leading supplier of fine chemicals, pharmaceutical intermediates, active pharmaceutical ingredients and other compounds. It also offers finished p...

Asia Pioneer Pharmaceuticals is a leading supplier of fine chemicals, pharmaceutical intermediates, active pharmaceutical ingredients and other compounds. It also offers finished product licensing, custom manufacturing and outsourcing services. In partnership with state-of-the-art manufacturers in China, Asia Pioneer provides world-class quality products at excellent value, in full compliance with standards required by leading regulatory agencies in the USA and Europe.
blank

07

CHEMO

Spain
Fi Europe 2024
Not Confirmed
arrow

CHEMO

Spain
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...

More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimica) and in Spain (Quimica Sintetica). In the 90's, CHEMO starts developing and manufacturing high quality and technology finished dosage forms (FDFs).
blank

08

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Chromo Laboratories India Pvt. Ltd, is a Hyderabad based Manufacturer of Intermediates and Active Pharmaceutical Ingredients. The manufacturing facility is located at Pashamylaram...

Chromo Laboratories India Pvt. Ltd, is a Hyderabad based Manufacturer of Intermediates and Active Pharmaceutical Ingredients. The manufacturing facility is located at Pashamylaram, Near Patancheru, Which is 27 KM from Hyderabad. It aggressively engage in expanding product portfolio strategy and focuses on its growth . Chromo Laboratories India views its fully equipped R&D centre capabilities as a vital component of its business strategy that will provide the company with a sustainable, long-term competitive advantage. It is focusing on providing cost effective products to the Pharmaceutical Market. 
blank

09

HELM Portugal

Portugal
Fi Europe 2024
Not Confirmed
arrow

HELM Portugal

Portugal
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : HELM Portugal is HELM’s Competence Centre for the marketing of Active Pharmaceutical Ingredients (API). The leading APIs distributed by Helm include Ascorbic Acid pharma Grade (C...

HELM Portugal is HELM’s Competence Centre for the marketing of Active Pharmaceutical Ingredients (API). The leading APIs distributed by Helm include Ascorbic Acid pharma Grade (CEP), Heparin Sodium (CEP holder), Dimetindene Maleate EP. Helm supply high-quality pharmaceuticals and provide a broad range of services on a global scale. Our services include: Logistics and distribution, Sourcing on Demand, Regulatory Affairs and Quality.
blank

10

Hetero Drugs

India
Fi Europe 2024
Not Confirmed
arrow

Hetero Drugs

India
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

11

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB reg...

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
blank

12

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets f...

Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
blank

13

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Suzhou Tianlu Bio-pharmaceutical Co.,Ltd., established in Dec.1999 covering an area of 26,666 square meters, is a high-tech shareholding company with a total investment of one hund...

Suzhou Tianlu Bio-pharmaceutical Co.,Ltd., established in Dec.1999 covering an area of 26,666 square meters, is a high-tech shareholding company with a total investment of one hundred millionyuan. As an influential producer of cholic products both in China and abroad, our company specializes in researching, developing, manufacturing and marketing biological APIs and pharmaceutical intermediates. At present, we have 10 invention patents and establish a technology research center of cholic products that undertakesmultiple national projects.
blank

14

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Teva Active Pharmaceutical Ingredients (TAPI) is a global leader in active pharmaceutical ingredients (APIs), with over 85 years of experience. As part of Teva Pharmaceuticals, TAP...

Teva Active Pharmaceutical Ingredients (TAPI) is a global leader in active pharmaceutical ingredients (APIs), with over 85 years of experience. As part of Teva Pharmaceuticals, TAPI offers a diverse portfolio of more than 300 high-quality APIs across a wide range of therapeutic areas. With cutting-edge R&D, state-of-the-art manufacturing facilities, and a strong global presence, TAPI is dedicated to innovation, quality, and compliance. We are a trusted partner, committed to supporting pharmaceutical companies in delivering life-changing medicines to patients worldwide.
blank

15

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank

16

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Titan Laboratories is leading EU GMP approved Site for Sustained and Modified Release Pellets, Direct Compressible Granules, Tablets & Capsules.Our major focus in EU market is for1...

Titan Laboratories is leading EU GMP approved Site for Sustained and Modified Release Pellets, Direct Compressible Granules, Tablets & Capsules.Our major focus in EU market is for1) CONTRACT MANUFACTURING SERVICES:-> As approved Dossier Manufacturer.-> Site variation basis.-> cGMP pilot batch for BE/BA or Clinical Studies.2) CONTRACT RESEARCH SERVICES:-> Product Development - Generic Equivalent, Novel Sustained & Combination Products-> Method Development & Validation-> Dossier Preparation-> Stability Studies
blank

17

Viatris

U.S.A
Fi Europe 2024
Not Confirmed
arrow

Viatris

U.S.A
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (N...

In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020.
blank

18

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceu...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
blank

19

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Founded in 2003, Zhejiang Tianyu Pharmaceutical Co., Ltd. is a joint-stock pharmaceutical company specializing in the research, development and manufacture of APIs and advanced pha...

Founded in 2003, Zhejiang Tianyu Pharmaceutical Co., Ltd. is a joint-stock pharmaceutical company specializing in the research, development and manufacture of APIs and advanced pharmaceutical intermediates. The company has a registered capital of 120 million yuan and covers an area of ​​700 mu. The factory has more than 2,600 employees.
blank

20

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Candesartan Cilexetil

About the Company : Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise integrating drug research and development, production, and sales. It is loc...

Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise integrating drug research and development, production, and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province. It was established in 1999. On January 5, 2018, the company was listed on the Shenzhen Stock Exchange (stock abbreviation: Rundu; stock code: 002923). The company's main business is the research and development, production, and sales of chemical-pharmaceutical preparations, chemical raw materials, and pharmaceutical intermediates. field.
blank